IL-32 was involved in cigarette smoke-induced pulmonary inflammation in COPD

Clinical Respiratory Journal

Volumn 9, Issue 4, 2015, Pages 430-435

  Rong, Yao ^a   Xiang, Xu dong ^a   Li, Ya min ^a   Peng, Zhen yu ^a   Li, Jin xiu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

COPD; Inflammation; Interleukin 32; Smoke

Indexed keywords

CIGARETTE SMOKE; INTERLEUKIN 32; INTERLEUKIN 6; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; IL32 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; CELL STIMULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN CELL; LUNG FUNCTION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; SPUTUM LEVEL; ADVERSE EFFECTS; AGED; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CELL CULTURE; DRUG EFFECTS; METABOLISM; MIDDLE AGED; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM; UPREGULATION;

AGED; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; HUMANS; INTERLEUKINS; MACROPHAGES; MALE; MIDDLE AGED; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPUTUM; UP-REGULATION;

EID: 84943357160     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12157     Document Type: Article

References (15)

1. Thomsen M, Ingebrigtsen TS, Marott JL, etal. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA. 2013;309: 2353-2361.
2. Thomsen M, Dahl M, Lange P, etal. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186: 982-988.
3. Dinarello CA, Kim SH. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis. 2006;65(Suppl. 3): iii61-64.
4. Choi JD, Bae SY, Hong JW, etal. Identification of the most active interleukin-32 isoform. Immunology. 2009;126: 535-542.
5. Joosten LA, Netea MG, Kim SH, etal. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA. 2006;103: 3298-3303.
6. Shioya M, Nishida A, Yagi Y, etal. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol. 2007;149: 480-486.
7. Calabrese F, Baraldo S, Bazzan E, etal. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178: 894-901.
8. Deng X, Zhang Z, Gu W, etal. Budesonide inhibits interleukin-32 expression in a rat model of chronic obstructive pulmonary disease. Exp Lung Res. 2012;38: 295-301.
9. Kudo M, Ogawa E, Kinose D, etal. Oxidative stress induced interleukin-32 mRNA expression in human bronchial epithelial cells. Respir Res. 2012;13: 19-29.
10. Vestbo J, Hurd SS, Agustí AG, etal. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187: 347-365.
11. Jiang Y, Xiao W, Zhang Y, etal. Urokinase-type plasminogen activator system and human cationic antimicrobial protein 18 in serum and induced sputum of patients with chronic obstructive pulmonary disease. Respirology. 2010;15: 939-946.
12. Zeng DX, Xu YJ, Liu XS, etal. Cigarette smoke extract induced rat pulmonary artery smooth muscle cells proliferation via PKCα-mediated cyclin D1 expression. J Cell Biochem. 2011;112: 2082-2088.
13. Xu Q, Pan X, Shu X, etal. Increased interleukin-32 expression in chronic hepatitis B virus-infected liver. J Infect. 2012;65: 336-342.
14. Wang H, Wang K, Wang C, etal. Increased plasma interleukin-32 expression in patients with neuromyelitis optica. J Clin Immunol. 2013;33: 666-670.
15. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8: 183-192.